[
  {
    "ts": null,
    "headline": "Reasons to Add AngioDynamics Stock to Your Portfolio for Now",
    "summary": "ANGO stock is buoyed by strong fiscal Q2 results, surging NanoKnife adoption in prostate cancer, and broad Med Tech growth supporting margins.",
    "url": "https://finnhub.io/api/news?id=b4f33f8d9cff6518084ac5084b3d7a16a84f2e18062ff9a2b1459b7fe4686448",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769708820,
      "headline": "Reasons to Add AngioDynamics Stock to Your Portfolio for Now",
      "id": 138298590,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "STE",
      "source": "Yahoo",
      "summary": "ANGO stock is buoyed by strong fiscal Q2 results, surging NanoKnife adoption in prostate cancer, and broad Med Tech growth supporting margins.",
      "url": "https://finnhub.io/api/news?id=b4f33f8d9cff6518084ac5084b3d7a16a84f2e18062ff9a2b1459b7fe4686448"
    }
  }
]